Search company, investor...



Acq - P2P | Acquired



About Penederm

Penederm creates drugs for the skin using transdermal drug delivery.

Headquarters Location

320 Lakeside Drive

Foster City, California, 95070,

United States


Missing: Penederm's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Penederm's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Penederm News


Apr 9, 2015

COMPANY NEWS; MYLAN LABS AND PENEDERM IN $205 MILLION DEAL Published: June 25, 1998 The generic drug maker Mylan Laboratories Inc. of Pittsburgh agreed yesterday to acquire Penederm Inc. in a deal valued at $205 million. Penederm, of Foster City, Calif., markets patented topically administered prescription products. Under the deal, Penederm shareholders will receive 0.68 share of Mylan common stock for each share of Penederm stock. The deal is valued at about $21.89 a share to Penederm shareholders based on the closing price of Mylan stock on Tuesday. Mylan shares fell 43.75 cents yesterday, to $31.75, while Penederm jumped $4.75, or 30 percent, to $20.50. The transaction is intended to qualify as a tax-free reorganization and is expected to close before the end of the year.

Penederm Frequently Asked Questions (FAQ)

  • Where is Penederm's headquarters?

    Penederm's headquarters is located at 320 Lakeside Drive, Foster City.

  • What is Penederm's latest funding round?

    Penederm's latest funding round is Acq - P2P.

  • Who are the investors of Penederm?

    Investors of Penederm include Mylan and ONSET Ventures.

  • Who are Penederm's competitors?

    Competitors of Penederm include Corium International, Anterios, Edge Therapeutics, Cellnovo, MediQuest Therapeutics and 12 more.

Compare Penederm to Competitors


Travanti offers transdermal delivery of drugs and cosmetic agents utilizing active-patch technology.

Travanti Pharma

Transdermal delivery of drugs and cosmetic agents utilizing active-patch technology. The company was acquired by Teikoku.

Imagine Pharmaceuticals

Imagine Pharmaceuticals is developing technology to facilitate delivery of drugs to the brain


EryDel develops a red-blood-cell-based drug delivery device for the treatment of rare neurodegenerative diseases. Its proprietary technology relies upon the encapsulation of drugs into red cells taken from the patient's own blood, which are then re-infused into the patient.

FORMAC Pharmaceuticals N.V.

FORMAC is a pharmaceutical R&D company engaged in drug delivery and development. The firm aims to increase pharmaceutical R&D productivity and product value by enhancing the performance of (pre)clinical drug candidates and marketed drugs.

Pantec Biosolutions Logo
Pantec Biosolutions

Pantec Biosolutions is a provider of transdermal drug delivery solutions.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.